This Syndicated News page contains articles for the last 30 days from a variety of news feeds related to the European Research Area. The list of articles is refreshed every 15 minutes so you can be sure of the latest information.
Click the following link to view the sources used on this page.
Minutes since last refreshed: 5 (07:47 on 25 May 2013)
The European Commission has today announced the 18 public authorities shortlisted for its competition to find the most innovative public initiatives in Europe. The finalists are competing for nine prizes worth €100,000 each. The purpose of the prizes is to encourage modern approaches to public spending, which accounts on average for half of EU gross domestic product. The prize money has to be used by winning administrations to scale up and expand their winning initiatives. [read more]
Cancer causes some 13% of deaths worldwide. Of these deaths, some 90% are caused not by the original cancer, but by its spread to other parts of the body. These secondary cancers, known as metastases, are most often caused by 'circulating tumour cells' (CTCs) which escape from the primary tumour and travel around the body in the bloodstream. In the process, CTCs often undergo modifications that make them more resistant to treatment than the primary tumours. [read more]
Source: What's New in Innovation
Cancer treatment is one of the most important areas of research in the medical world today. With research predominately conducted in large pharmaceutical research organisations, it is rather significant to hear of small medium enterprises (SMEs) developing their own innovative treatment for cancer. Two small research-based pharmaceutical companies BioInvent (the primary coordinator), in Sweden and Thrombogenics in Belgium, joined together with three other partners to form the ANGIOSTOP project, with EU-funding of nearly EUR 2 million. Quality validation date: 2013-05-13 [read more]
From Roman temples and Gothic churches to Greek theatres and medieval castles, Europe is peppered with historic buildings that reflect its rich cultural heritage. But these monuments all need to be preserved, a task complicated by age, pollution, tourist demands and climate change. Now science is lending a hand in this task, with a new European Union research project developing measures to reduce energy loss from within old buildings. [read more]
Nuclear power accounts for one sixth of the European Union (EU)'s energy consumption, and there are power plants in 14 of the 27 member states. Safety is a priority and there are regular maintenance checks on every aspect of the plants. But what happens if cracks appear in the machinery that are so small and deep that they escape the human eye? And how can one check every corner of a nuclear reactor when some areas are, by necessity, shrouded in radiation? [read more]
When Europe's rail pioneers created the first steam engines some two centuries ago, they gave little thought to whether their inventions might be used in other countries: while their ingenuity helped transform travel, they never got round to setting uniform rail technologies across the continent. [read more]
Well, in fact I was quite longing for the level of living or the European style of living. For example, work hard and rest much, and they have more time with the family, and I like that very much. But for example, I’m sorry for the Italian people or the Greek people, but they do not work so hard. I think. I mean the time… the time is quite, little I think. So that is one of the problems of the crisis. [read more]
I think research and innovation do certainly...can guide us for a better future, At the same time, I would say, we need to define innovation, because I believe that we have a certain concept of what innovation means, at this current time...meaning especiallly technological innovation but I also feel that it's gonna be destruction if we only focus on the technological innovation. So, I believe that research can help us more if it focuses on health and issues that are important to people. [read more]
There are simply mega things that would not have happened without research. I refered, before we talked, to digital mapping, companies like Tele Atlas, Navteq, would not have that kind of existence without this kind of research. On the other hand, the efficiency is by far too low. When you talk about - and I'm sorry to say so - about research and the EU level, the efficiency is low, the bureaucracy is far too high also in other organizations, of course, and the companies, it's too high. [read more]
To mark the European Month of the Brain, we look at one EU-funded project that has focussed efforts on drug delivery across the so-called blood-brain barrier. The blood-brain barrier (BBB), while preforming a key protective function, is now recognised as the major obstacle in the treatment of most neurological disorders. It hinders the delivery of many potentially important therapeutic and diagnostic substances to the central nervous system (CNS). Quality validation date: 2013-05-10 [read more]